drugset / Trial / NCT06980142
A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase II Study to Explore the Efficacy and Safety of CM512 Injection in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Timeline
- Start
- 2025-06-20
- Primary completion
- 2028-03-17
- Completion
- 2028-03-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CM512 | Unknown | — | Subcutaneous |